Implant dosage form and use thereof for the delivery of a cholesterol lowering agent

Details for Australian Patent Application No. 2002258361 (hide)

Owner DURECT CORPORATION

Inventors Struijkerboudier-Boudier, Harry, A., J.

Agent FB Rice

Pub. Number AU-A-2002258361

PCT Pub. Number WO2002/067895

Priority 60/249,644 16.11.00 US

Filing date 8 November 2001

Wipo publication date 12 September 2002

International Classifications

A61K 009/00 Medicinal preparations characterised by special physical form

Event Publications

6 March 2003 Application Open to Public Inspection

  Published as AU-A-2002258361

4 October 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002258362-DUAL MODE UPLINK/DOWNLINK LOCATION MEASUREMENT AND MULTI-PROTOCOL LOCATION MEASUREMENT

2002258360-METHOD AND SYSTEM FOR A BIDIRECTIONAL PATH SWITCHED NETWORK